
Mon, 30 May 2022 China Legal Trends CJO Staff Contributors Team
In April 2022, Beijing Intellectual Property Court announced the first-instance judgment of the case Chugai Pharmaceutical Co., Ltd. v. Wenzhou Haihe Pharmaceutical Co., Ltd., addressing whether the generic drug in question falls within the protection scope of relevant patent rights.